Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer

NCT05420584 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Rectal Neoplasms

Interventions

PROCEDURE: Arterial chemoembolization
DRUG: Tislelizumab Injection
DRUG: XELOX
DIAGNOSTIC_TEST: Pelvic MRI
PROCEDURE: Laparoscopic radical resection of rectal cancer

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine

Collaborators

[object Object]